regulatory milestone
Predetermined checkpoint in drug development representing significant progress toward regulatory approval.
Full Definition
A regulatory milestone is a predefined achievement point in the drug development process that marks significant progress toward obtaining marketing authorization from regulatory agencies. These milestones typically include submission deadlines, regulatory meeting outcomes, and approval decisions. In psychiatric drug development, key milestones include IND filing, End-of-Phase 2 meetings with FDA, NDA or MAA submission, and approval decisions. Regulatory milestones serve as critical planning tools for pharmaceutical companies, affecting resource allocation, partnership agreements, and financial projections. Achievement of milestones often triggers payment obligations in licensing agreements and influences investor confidence.
Usage
Usage note: Hyphenate when used as compound modifier: 'regulatory-milestone payment'.
In Context
- "The company achieved a key regulatory milestone with FDA's acceptance of the NDA filing." — Press release
- "Missing the regulatory milestone for Phase III initiation delayed the development timeline by six months." — Development report